The potential risk of AVM rupture was evaluated while in the A Randomized demo of Unruptured Brain Arteriovenous malformations (ARUBA) trial. This study exposed a decreased danger of stroke and mortality in people managed conservatively versus patients who underwent interventional therapy.[13]  The ARUBA trial as opposed clinical management on your https://www.sgvascularctr.com/service/vascular-malformations/